Skip to content

Pilonidal Sinus Disease

LASER ABLATION VERSUS KARYDAKIS TECHNIQUE IN THE TREATMENT OF PILONIDAL SINUS DISEASE: A COMPARATIVE STUDY

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06508086
Enrollment
30
Registered
2024-07-18
Start date
2024-06-10
Completion date
2025-06-01
Last updated
2024-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Sinus

Brief summary

The aim of this study is to compare the outcomes of Karydakis technique versus sinus tract ablation procedure using 1470 nm Diode laser for the treatment of pilonidal sinus and provide evidence-based guidance to select the most appropriate operative procedure.

Interventions

PROCEDURElaser ablation technique in the treatment of pilonidal sinus

group (A) will include patients with pilonidal sinus disease who will be operated by sinus tract ablation procedure using 1470 nm Diode laser

PROCEDUREKarydakis technique in the treatment of pilonidal sinus

group (B) will include patients with pilonidal sinus disease who will be operated by Karydakis technique

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with a clinical diagnosis of symptomatic uncomplicated pilonidal sinus, males or females, any age will be included in our study.

Exclusion criteria

* Patients with pilonidal abscess and any associated acute condition. * Patients with hidradenitis suppurativa. * Refusal. * Unfit for surgery. * Recurrence.

Design outcomes

Primary

MeasureTime frameDescription
recurrence rate in the treatment of pilonidal disease6 months after the operationthe patients undergo follow up at the outpatient clinic for manifestations of recurrence eg. discharge, multiple pits

Countries

Egypt

Contacts

Primary ContactAssem M Ahmed, Resident
asemereby3@gmail.com01111544547

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026